Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Atherogenesis and metabolic dysregulation in LDL receptor–knockout rats
Srinivas D. Sithu, … , Aruni Bhatnagar, Sanjay Srivastava
Srinivas D. Sithu, … , Aruni Bhatnagar, Sanjay Srivastava
Published May 4, 2017
Citation Information: JCI Insight. 2017;2(9):e86442. https://doi.org/10.1172/jci.insight.86442.
View: Text | PDF
Research Article Cardiology Vascular biology

Atherogenesis and metabolic dysregulation in LDL receptor–knockout rats

  • Text
  • PDF
Abstract

Mechanisms of atherogenesis have been studied extensively in genetically engineered mice with disturbed cholesterol metabolism such as those lacking either the LDL receptor (Ldlr) or apolipoprotein E (apoe). Few other animal models of atherosclerosis are available. WT rabbits or rats, even on high-fat or high-cholesterol diets, develop sparse atherosclerotic lesions. We examined the effects of Ldlr deletion on lipoprotein metabolism and atherosclerotic lesion formation in Sprague-Dawley rats. Deletion of Ldlr resulted in the loss of the LDLR protein and caused a significant increase in plasma total cholesterol and triglycerides. On normal chow, Ldlr-KO rats gained more weight and were more glucose intolerant than WT rats. Plasma proprotein convertase subtilisin kexin 9 (PCSK9) and leptin levels were higher and adiponectin levels were lower in KO than WT rats. On the Western diet, the KO rats displayed exaggerated obesity and age-dependent increases in glucose intolerance. No appreciable aortic lesions were observed in KO rats fed normal chow for 64 weeks or Western diet for 16 weeks; however, after 34–52 weeks of Western diet, the KO rats developed exuberant atherosclerotic lesions in the aortic arch and throughout the abdominal aorta. The Ldlr-KO rat may be a useful model for studying obesity, insulin resistance, and early-stage atherosclerosis.

Authors

Srinivas D. Sithu, Marina V. Malovichko, Krista A. Riggs, Nalinie S. Wickramasinghe, Millicent G. Winner, Abhinav Agarwal, Rihab E. Hamed-Berair, Anuradha Kalani, Daniel W. Riggs, Aruni Bhatnagar, Sanjay Srivastava

×

Figure 1

Dyslipidemia in Ldlr-KO rats.

Options: View larger image (or click on image) Download as PowerPoint
Dyslipidemia in Ldlr-KO rats.
Rats were maintained on normal chow (NC) f...
Rats were maintained on normal chow (NC) for 64 weeks, and blood and liver were collected following a 6h fast. (A) Representative Western blots (n = 3–4/group) of liver homogenates of Ldlr-KO and WT rats probed with anti–LDL receptor; anti-ATP–binding cassette, subfamily A, member 1 (ABCA1); and anti-ATP–binding cassette, subfamily G1 (ABCG1) antibodies. (B) Quantitative PCR analyses for the mRNA expression of lipoprotein receptors in the liver of Ldlr-KO and WT rats (n = 5/group). (C and D) The time course of plasma cholesterol and triglyceride levels respectively of Ldlr-KO (n = 5–9) and WT (n = 5–9) rats. (E) The plasma proprotein convertase subtilisin kexin 9 (PCSK9) levels in 62-week-old rats (n = 6–8/group). Unpaired 2-tailed Student’s t test was used for the analyses of data in panels B and E, and 2-way ANOVA was used for the analyses of data in panels C and D. Values are mean ± SEM. *P < 0.05 vs. WT rats.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts